Pre-ERAS group (2009–14) (n=29) | Post-ERAS group (2015–20) (n=52) | P value | |
Age (years) (median (IQR)) | 42 (35–53) | 41 (35–49) | 0.47 |
Body mass index (kg/m2) (median (IQR)) | 26.1 (24.6–29.7) | 27.1 (23.5–33.5) | 0.44 |
American Society of Anesthesiologists classification (n (%)) | 0.76 | ||
II | 1 (3.4) | 7 (13.5) | |
III | 9 (31.0) | 45 (86.5) | |
Missing | 19 (65.5) | 0 (0) | |
Preoperative stage (n (%)) | 0.24 | ||
IA1 | 2 (6.9) | 3 (5.8) | |
IA2 | 3 (10.3) | 10 (19.2) | |
IB1 | 23 (79.3) | 34 (65.4) | |
IB2 | 0 (0.0) | 4 (7.7) | |
IIA1 | 1 (3.4) | 0 (0) | |
Missing | 0 (0) | 1 (1.9) | |
Preoperative hemoglobin (g/dL) (median (IQR)) | 13.6 (11.5–14.5) | 13.1 (12.1–13.8) | 0.46 |
Duration of surgery (minutes) (median (IQR)) | 244 (195–302) | 272 (243–306) | 0.07 |
Blood loss (mL) (median (IQR)) | 300 (200–550) | 325 (150–500) | 0.84 |
Pathology grade (n (%)) | 0.15 | ||
I | 2 (6.9) | 2 (3.8) | |
II | 8 (27.6) | 20 (38.5) | |
III | 8 (27.6) | 22 (42.3) | |
Unknown | 11 (37.9) | 8 (15.4) | |
Histology (n (%)) | 0.19 | ||
Squamous | 6 (20.7) | 21 (40.4) | |
Adenocarcinoma | 9 (31.0) | 11 (21.1) | |
Adenosquamous | 2 (6.9) | 4 (7.7) | |
Neuroendocrine | 1 (3.5) | 0 (0) | |
Undifferentiated | 1 (3.5) | 0 (0) | |
No residual tumor | 8 (27.6) | 9 (17.3) | |
Mixed | 0 (0) | 2 (3.8) | |
Other | 2 (6.9) | 5 (9.6) |